iasusa

Carlos del Rio, MD Hot Topics in HIV Medicine: A Special IAS-USA CME Course February 5, 2021 27 minutes and 48 seconds

Kristine M. Erlandson, MD, MS Hot Topics in HIV Medicine: A Special IAS-USA CME Course February 5, 2021 36 minutes and 44 seconds

Susan P. Buchbinder, MD Hot Topics in HIV Medicine: A Special IAS-USA CME Course February 5, 2021 36 minutes and 14 seconds

Eric S. Daar, MD Hot Topics in HIV Medicine: A Special IAS-USA CME Course February 5, 2021 36 minutes and 8 seconds

E. Turner Overton, MD Hot Topics in HIV Medicine: A Special IAS-USA CME Course February 5, 2021 35 minutes and 51 seconds

Update on SARS-CoV-2 Variants, Vaccine Development, and Decreasing the Case Rate (January 29, 2021) by iasusa

Update on COVID-19 Vaccines (January 4, 2021) by iasusa

Impact of the COVID-19 on HCV and STIs (November 23, 2020) by iasusa

Ann R. Falsey, MD 2020 National IAS–USA Virtual Update Course on HIV Management November 12, 2020

Expert Panelists: Roger Bedimo, MD, MS, Judith Currier, MD, Jodie Dionne-Odom, MD, Henry Masur, MD, and Susan Swindells, MBBS Case Presenter: Michael S. Saag, MD

Gregorio A. Millet, MPH 2020 National IAS–USA Virtual Update Course on HIV Management November 12, 2020

Expert Panelists: Roger Bedimo, MD, MS, Connie L. Celum, MD, MPH, E. Turner Overton, MD, and Michael S. Saag, MD Case Presenter: Monica Gandhi, MD, MPH 2020 National IAS–USA Virtual Update Course on HIV Management November 12, 2020

Henry Masur, MD 2020 National IAS–USA Virtual Update Course on HIV Management November 12, 2020

Moderated by: Rajesh T. Gandhi, MD Panelists: Constance A. Benson, Carlos del Rio, MD, Michael S. Saag, MD, Paul E. Sax, MD, Davey M. Smith, MD, Melanie A. Thompson, MD, and Paul A. Volberding, MD 2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults October 29, 2020

Moderated by: Carlos del Rio, MD Panelists: Constance A. Benson, MD, Rajesh T. Gandhi, MD, Michael S. Saag, MD, Paul E. Sax, MD, Davey M. Smith,MD, Paul A. Volberding, MD 2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults October 29, 2020

Moderated by: Paul E. Sax, MD Panelists: Constance A. Benson, MD, Carlos del Rio, MD, Rajesh T. Gandhi, MD, Michael S. Saag, MD, Davey M. Smith,MD, Melanie A. Thompson, MD,Paul A. Volberding, MD 2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults October 29, 2020

Moderated by: Davey M. Smith, MD Panelists: Constance A. Benson, MD, Carlos del Rio, MD, Rajesh T. Gandhi, MD, Michael S. Saag, MD, Paul E. Sax, MD, Paul A. Volberding, MD 2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults October 29, 2020

Moderated by: Raphael J. Landovitz, MD, MSc Panelists: Susan P. Buchbinder, MD, Carlos del Rio, MD, Rajesh T. Gandhi, MD, Jean-Michel Molina, MD, Michael S. Saag, MD, Davey M. Smith,MD, Paul A. Volberding, MD 2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults October 29, 2020

Moderated by: Jennifer F. Hoy, MBBS Panelists: Carlos del Rio, MD, Rajesh T. Gandhi, MD, Michael S. Saag, MD, Davey M. Smith,MD, Melanie A. Thompson, MD, Paul A. Volberding, MD 2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults October 29, 2020

Rajesh T. Gandhi, MD 2020 IAS-USA Guidelines: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults October 29, 2020

Lessons From the Lab: Implications for Coronavirus Vaccine and Therapeutics (October 19, 2020) by iasusa

Addressing Questions About COVID-19 (September 23, 2020) by iasusa

HIV and COVID-19 Interactions and Parallels in Advocacy (September 15, 2020) by iasusa

New Strategies and Challenges of PrEP in the COVID-19 Era (September 9, 2020) by iasusa

Continued Discussion on COVID-19 Epidemiology and Transmission (August 19, 2020) by iasusa